Stock Analiz

Pfizer Inc. (PFE) stock forecast and price target

Price $28.89 · data as of November 13, 2026

12-month price target

Average target$30.22
Upside / downside+4.6%
Analysts26
ConsensusBuy
Low $25.00Average $30.22High $37.00

Gold marker: average target · white marker: today’s price ($28.89)

Analyst ratings

Strong buy 1Buy 8Hold 17Sell 1Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$3.05−5.2%$63.1B
Next fiscal year
ends December 31, 2027
$2.95−3.4%$60.8B
Next quarter
ends December 31, 2026
$0.69+4.6%$17.2B
Quarter after
ends March 31, 2027
$0.70−7.0%$14.1B

Consensus of the analysts covering Pfizer, updated daily. In the last 30 days 16 estimates were raised and 4 lowered.

Our model vs. Wall Street

Analysts see 4.6% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Pfizer’s intrinsic value about 31% below today’s market value, and it scores 2.2 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Pfizer stock price target?

The average 12-month target from 26 analysts is $30.22, 4.6% above the current price of $28.89 Targets range from $25.00 to $37.00.

Is Pfizer a buy according to analysts?

The consensus rating is “Buy” (1 strong buy, 8 buy, 17 hold, 1 sell, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Pfizer expected to earn?

Analysts expect EPS of $3.05 for the fiscal year ending December 31, 2026 and $2.95 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.